REV·1 Engineering’s medical device development typically gets clients to CE and FDA approvals before it is necessary to build a commercialization team. Most of our successful clients have not needed to hire full-time employees, other than C-level, prior to series C funding. This creates a very fast and capital-efficient model to get to a potential acquisition or confident funding of commercialization.
REV·1 also understands that there are many “customers” in the commercialization chain. From health care administrators measured by budgets and insurance reimbursement amounts to physicians measured by how quickly they can produce life-changing results… to the ultimate customer, the patient, whose life is saved or improved dramatically by these medical devices. Their results are the true measure of our work.
With REV.1 you’ll push to your funding goals 2x Faster than it would take with a start-up in-house team. Give us a call at 951.696.3933, connect with us on LinkedIn, or send us an email at firstname.lastname@example.org, and let’s get your project moving toward full funding.